APA (7th ed.) Citation

JS, S., MA, B., HSB, B., A, B., LW, M., W, H., . . . Investigators, P. P. 2. S. (2008). Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study. Arthritis & Rheumatism, 58(9), 2882. https://doi.org/10.1002/art.23810

Chicago Style (17th ed.) Citation

JS, Sundy, et al. "Reduction of Plasma Urate Levels Following Treatment with Multiple Doses of Pegloticase (polyethylene Glycol-conjugated Uricase) in Patients with Treatment-failure Gout: Results of a Phase II Randomized Study." Arthritis & Rheumatism 58, no. 9 (2008): 2882. https://doi.org/10.1002/art.23810.

MLA (9th ed.) Citation

JS, Sundy, et al. "Reduction of Plasma Urate Levels Following Treatment with Multiple Doses of Pegloticase (polyethylene Glycol-conjugated Uricase) in Patients with Treatment-failure Gout: Results of a Phase II Randomized Study." Arthritis & Rheumatism, vol. 58, no. 9, 2008, p. 2882, https://doi.org/10.1002/art.23810.